Brace recommends that patients be within 5-10 pounds of their ideal weight before undergoing facial cosmetic surgery
The clinical development program has demonstrated unprecedented efficacy that exceeds any currently available obesity pharmacotherapy
Cultural and language barriers may also contribute to the under-reporting of negative or inconclusive results, 23 thereby increasing the likelihood of publication bias
Sango K, Takaku S, Tsukamoto M, Niimi N, Yako H (2022) Glucagon-like Peptide-1 receptor agonists as potential myelination-inducible and anti-demyelinating remedies
Additionally, over three times the number of people taking the drug achieved a 5% reduction, a generally accepted baseline for clinically meaningful weight loss
Owing to its unique structure and mode of action, SS-31 demonstrates potential therapeutic value across cardiovascular diseases, neurodegenerative disorders, kidney injury, and myopathies associated with mitochondrial dysfunction 1-6
